Cite
Six-Year Clinical Results of an IgA-and IgM-Enriched Human Immunoglobulin-Based Therapy for Early Anti-HLA Donor Specific Antibodies after Lung Transplantation
MLA
Axel Haverich, et al. “Six-Year Clinical Results of an IgA-and IgM-Enriched Human Immunoglobulin-Based Therapy for Early Anti-HLA Donor Specific Antibodies after Lung Transplantation.” The Thoracic and Cardiovascular Surgeon, Jan. 2020. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........c42160bef43a4b9d8755c856787412d3&authtype=sso&custid=ns315887.
APA
Axel Haverich, Igor Tudorache, Murat Avsar, Gregor Warnecke, Fabio Ius, Nicolaus Schwerk, Thierry Siemeni, Jawad Salman, Wiebke Sommer, & Christian Kühn. (2020). Six-Year Clinical Results of an IgA-and IgM-Enriched Human Immunoglobulin-Based Therapy for Early Anti-HLA Donor Specific Antibodies after Lung Transplantation. The Thoracic and Cardiovascular Surgeon.
Chicago
Axel Haverich, Igor Tudorache, Murat Avsar, Gregor Warnecke, Fabio Ius, Nicolaus Schwerk, Thierry Siemeni, Jawad Salman, Wiebke Sommer, and Christian Kühn. 2020. “Six-Year Clinical Results of an IgA-and IgM-Enriched Human Immunoglobulin-Based Therapy for Early Anti-HLA Donor Specific Antibodies after Lung Transplantation.” The Thoracic and Cardiovascular Surgeon, January. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........c42160bef43a4b9d8755c856787412d3&authtype=sso&custid=ns315887.